Nifedipine-retard alone and incombination with metoprolol: comparative efficacy andsafety in patients with arterial hypertension
- 作者: Isaikina O1, Gorbunov V1, Andreeva G1, Dmitrieva N1, Martsevich S1
-
隶属关系:
- ГНИЦ профилактической медицины Минздрава РФ
- 期: 卷 78, 编号 12 (2003)
- 页面: 39-42
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/29704
- ID: 29704
如何引用文章
全文:
详细
monotherapy and in combination with metoprolol (egilok, Egis, Hungary) in patients with arterial hypertension (AH).
Material and methods. The study included 20 patients with AH stage I-II (12 males, 8 females,
mean age 57.3 years, mean duration of the disease 8.6 years). Nifedipin-retard was given in a daily
dose 40 mg/day (20 mg twice a day) in monotherapy and 20 mg/day in combination with metoprolol
which was administered 50 mg twice a day (a daily dose 100 mg/day). The control examination consisted of a physical examination, measurement of arterial pressure (AP) by Korotkov, registration of
heart rate, ECG, 24-h AP monitoring, echocardiography.
Results. By 24-h AP monitoring, a 4-week treatment with nifedipin-retard alone resulted in lowering
of systolic arterial pressure. The combined treatment produced a more pronounced fall both in systolic
and diastolic pressure. Diastolic left-ventricular function improved in combined therapy. Side effects
observed in nifedipin-retard monotherapy got much more weaker when this drug combined with metoprolol.
Conclusion. Combination of nifedipin-retard with metoprolol provides better clinical response and tolerance than monotherapy with nifedipin-retard.
作者简介
O Isaikina
ГНИЦ профилактической медицины Минздрава РФГНИЦ профилактической медицины Минздрава РФ
V Gorbunov
ГНИЦ профилактической медицины Минздрава РФГНИЦ профилактической медицины Минздрава РФ
G Andreeva
ГНИЦ профилактической медицины Минздрава РФГНИЦ профилактической медицины Минздрава РФ
N Dmitrieva
ГНИЦ профилактической медицины Минздрава РФГНИЦ профилактической медицины Минздрава РФ
S Martsevich
ГНИЦ профилактической медицины Минздрава РФГНИЦ профилактической медицины Минздрава РФ
参考
- Gong L., Zhang W., Zhu J. et al. Shanghai Trial Of Nifedipine in the Elderly (STONE). J. Hypertens. 1996; 14: 1237-1245.
- Hansson L., Zanchetti A., Carruthers S. G. et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
- Joint National Committee on Prevention, Detection, Evalua- tion, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 1997; 157: 2413-2446.
- World Health Organization-International Society of Hypertension. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommitee. J. Hypertens 1999; 17: 151.
- Профилактика, диагностика и лечение первичной артериальной гипертонии в Российской Федерации (ДАГ-1). Клин, фармакол. и фармакотер. 2000; 3: 5-31.
- ANAES Agence Nationale d'Accreditation et d'Evaluation en Sante Recommandations. 2000. 1-17.
- White W. В., Dey H. M., Schulman P. Assessment of the daily pressure load as a determine of cardiac function in patients with mild-to moderate hypertension. Am. Heart J. 1989; 118: 782-795.
- Strauer B. E., Schwartzkopff B. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve. Am. J. Hypertens. 1998; 11: 879-881.